Pfizer beats profit estimates, ups earnings forecast Pfizer has today posted third-quarter profit well above analysts' estimates on higher sales of cancer drug Ibrance and new heart medicine Vyndaqel. Business • 29 Oct 19
Pfizer beats profit estimates, ups earnings forecast Pfizer has today posted third-quarter profit well above analysts' estimates on higher sales of cancer drug Ibrance and new heart medicine Vyndaqel. Business • 29 Oct 19
Pfizer sales miss as breast cancer drug disappoints Leading US drugmaker Pfizer racked up its biggest miss on sales in a year in the first quarter, hurt by lower than expected sales of blockbuster breast cancer drug Ibrance and arthritis drug Xeljanz. Business • 01 May 18
Pfizer sales miss as breast cancer drug disappoints Leading US drugmaker Pfizer racked up its biggest miss on sales in a year in the first quarter, hurt by lower than expected sales of blockbuster breast cancer drug Ibrance and arthritis drug Xeljanz. Business • 01 May 18
Pfizer revenue misses estimates as top drugs disappoint Pfizer, the largest US drugmaker, reported quarterly revenue that missed estimates as sales of its key drugs fell short of expectations. Business • 02 May 17
Pfizer revenue misses estimates as top drugs disappoint Pfizer, the largest US drugmaker, reported quarterly revenue that missed estimates as sales of its key drugs fell short of expectations. Business • 02 May 17
